Mack named to board of directors of neurointerventional surgery society

William J. Mack, MD, was named to the board of directors of the Society of NeuroInterventional Surgery (SNIS) at the group’s Annual Meeting. In this position, Mack, an assistant professor in the Department of Neurological Surgery at the Zilkha Neurogenetic Institute, will play a leading role with the society in continuing initiatives to resource, train and support veteran and new practitioners to bring advanced treatment approaches to neurovascular conditions. … Read More »

September 6th, 2013|Announcements|

Second annual Roxanna Todd Hodges lecture highlights stroke reduction

The second annual Roxanna Todd Hodges Visiting Lectureship in Stroke Prevention and Education was awarded to Cheryl Bushnell, MD, MHS, associate professor of neurology at Wake Forest School of Medicine. Bushnell is director of the Wake Forest Baptist Stroke Center and a thought leader in issues regarding women’s health and stroke, and performing community interventions for reducing stroke risk.

Bushnell’s lecture, “21st Century Stroke Prevention: What will it look like?” was presented at Neurology Grand Rounds held the morning of Aug. 6 at the Zilkha Neurogenetic Institute, part of the Keck School of Medicine of USC.

… Read More »

August 30th, 2013|Announcements|

ZNI researcher receives grant to study the changing nature of amyloid proteins

By Amy E. Hamaker

Amyloid fibers, abnormal protein aggregates, have been associated with more than 20 serious human diseases, including neurological disorders such as Alzheimer’s, Parkinson’s and Huntington’s diseases.

However, Ansgar Siemer, PhD, assistant professor of biochemistry and molecular biology at the Zilkha Neurogenetic Institute within the Keck School of Medicine of USC, is working on some amyloid fibers that can actually be necessary for long-term memory in fruit flies and other organisms.

Siemer will have the chance to research how this is possible thanks to a recent three-year award from the Whitehall Foundation. … Read More »

August 13th, 2013|Announcements|

New USC research points to prospective avenue of treatment for Alzheimer’s patients

By Sara Reeve

A USC team of scientists has published research that highlights a new potential therapeutic agent for patients with Alzheimer’s disease.

Researchers from the Zilkha Neurogenetic Institute at the Keck School of Medicine of USC have found that a mutant protein helps to bind amyloid beta peptide in the brain more efficiently than a wild type — or naturally occurring — version. Amyloid beta peptide (Aβ) is a primary component of amyloid plaques — deposits found in the brains of Alzheimer’s disease patients — and most researchers believe it plays a central role in the development of Alzheimer’s.  … Read More »

June 24th, 2013|Announcements|

Research points to prospective treatment for Alzheimer’s patients

By Sara Reeve

A USC team of scientists has published research that highlights a new potential therapeutic agent for patients with Alzheimer’s disease.

Researchers from the Zilkha Neurogenetic Institute at the Keck School of Medicine of USC have found that a mutant protein helps to bind amyloid beta peptide in the brain more efficiently than a wild type — or naturally occurring — version. Amyloid beta peptide (Aβ) is a primary component of amyloid plaques — deposits found in the brains of Alzheimer’s disease patients — and most researchers believe it plays a central role in the development of Alzheimer’s. … Read More »

June 21st, 2013|Announcements|